Continuous-Monitoring Blood Culture Screening System Improves the Detection of Bacteremia in Neutropenic Patients

References

• Bodey GP, Buckley M, Sathe YS, Freireich EJ. Quantitative relationships between circulating leukocytes and infection in patients with acute leukemia. Ann Intern Med 1966; 64: 328–340
   PubMed Web of Science ®Google Scholar
• Feld R. The compromised host. Eur J Cancer Clin Oncol 1989; 25(Suppl 2)1–7
   Google Scholar
• Hughes WT, Armstrong D, Bodey GP, Feld R, Mandell GL, Meyers JD, Pizzo PA, The Working Committee, Infectious Diseases Society of America. Guidelines for the use of antimicrobial agents in neutropenic patients with unexplained fever. J Infect Dis 1990; 161: 381–396
   PubMed Web of Science ®Google Scholar
• Bodey GP, Buckley M, Satha YS, Freireich EJ. Quantitative relationships between cicrulating leukocytes and infection in patients with acute leukemia. Ann Intern Med 1966; 64: 328–340
   PubMed Web of Science ®Google Scholar
• Gurwith MJ, Brunton JL, Lank BA, Ronald AR, Harding G KM. Granulocytopenia in hospitalized patients. I. Prognostic factors and etiology of fever. Am J Med 1978; 64: 121–126
   PubMed Web of Science ®Google Scholar
• Klastersky J, Zinner SH, Calandra T, Gaya H, Glauser MP, Meunier F, Rossi M, Schimpff SC, Tattershall M, Viscoli C, The E ORTC. Empiric antimicrobial therapy for febrile granulocytopenic cancer patients: lessons from four EORTC trials. Eur J Cancer Clin Oncol 1988; 24(Suppl 1)35–45
   PubMedGoogle Scholar
• Pizzo PA. Management of fever in patients with cancer and treatment-induced neutropenia. N Engl J Med 1993; 328: 1323–1332
   PubMed Web of Science ®Google Scholar
• Rintala E. Incidence and clinical significance of positive blood cultures in febrile episodes of patients with hematological malignancies. Scand J Infect Dis 1994; 26: 77–84
   PubMed Web of Science ®Google Scholar
• The International Antimicrobial Therapy Cooperative Group of the European Organization for Research and Treatment of Cancer. Efficacy and toxicity of single daily doses of amicasin and ceftriaxone versus multiple daily doses of amicasin and ceftazidime for infection in patients with cancer and granulocytopenia. Ann Intern Med 1993; 119: 584–593
   PubMed Web of Science ®Google Scholar
• Klastersky J. Empiric treatment of infections in neutropenic patients with cancer. Rev Infect Dis 1983; 5(Suppl 2)21–31
   Google Scholar
• Pizzo PA, Hathorm JW, Hiemenz J, Browne M, Commers J, Cotton D, Gress J, Longo D, Marshall D, McKnight J, Rubin M, Skeleton J, Thaler M, Wesley R. A randomized trial comparing ceftazidime alone with combination antibiotic therapy in cancer patients with fever and neutropenia. N Engl J Med 1986; 315: 552–558
   PubMed Web of Science ®Google Scholar
• Lieschke GH, Bell D, Rawlinson W, Green MD, Sheridan W, Morstyn G. Empiric single agent or combination antibiotic therapy for febrile episodes in neutropenic patients: an overview. Eur J Cancer Clin Oncol 1989; 25(Suppl 2)37–42
   Google Scholar
• Hirotsu T, Akatsuka J. Infectious complications in childhood leukemia. Acta Paediatr. Jpn 1991; 33: 564–572
   Google Scholar
• Bodet CA, 3d, Jorgensen JH, Drutz DJ. Antibacterial activities of antineoplastic agents. Antimicrob Agents Chemother 1985; 2: 437–439
   Google Scholar
• Bennet JM, Catowsky D, Daniel MT, Flandrin G, Galton D AG, Gralnick HD, Sultan C. Proposals for the classification of acute leukemias. Br J Haematol 1976; 33: 451–458
   PubMed Web of Science ®Google Scholar
• Elonen E, for the Finnish Leukaemia Group. Intensive chemotherapy of adult acute myelogenous leukemia: a randomized trial between 4 and 8 cycles. Blood 1993; 82(Suppl 1)328a
   PubMedGoogle Scholar
• Thorpe TC, Wilson ML, Turner JE, DiGuiseppi JL, Willert M, Mirrett S, Reller B. BacT/Alert: an automated colorimetric microbial detection system. J Clin Microbiol 1990; 28: 1608–1612
   PubMed Web of Science ®Google Scholar
• Schoefield KP, Voulgari F, Gozzard DI, Leyland MJ, Beeching NJ, Stuart J. C-Reactive protein concentration as a guide to antibiotic therapy in acute leukaemia. J Clin Pathol 1982; 35: 866–869
   PubMed Web of Science ®Google Scholar
• Timonen T TT, Koistinen P. C-reactive protein for detection and follow-up of bacterial and fungal infections in severely neutropenic patients with acute leukaemia. Eur J Cancer Clin Oncol 1985; 21: 557–562
   PubMedGoogle Scholar
• Santolaya ME, Cofre J, Beresi V. C-Reactive protein: a valuable aid for the management of febrile children with cancer and neutropenia. Clin Infect Dis 1994; 18: 589–595
   PubMed Web of Science ®Google Scholar
• Kostiala A AI, Kostiala I, Valtonen VV, Teerenhovi L. Levels of C-reactive protein in patients with hematologic malignancies. Scand J Infect Dis 1985; 17: 407–410
   PubMedGoogle Scholar
• Riikonen P. Imipenem compared with ceftazidime plus vancomycin as initial therapy for fever in neutropenic children with cancer. Pediatr Infect Dis J 1991; 10: 918–923
   PubMed Web of Science ®Google Scholar
• Weinstein MP, Mirrett S, Wilson ML, Reimer LG, Reller LB. Controlled evaluation of 5 versus 10 milliliters of blood cultured in aerobic BacT/Alert blood culture bottles. J Clin Microbiol 1994; 32: 2103–2106
   PubMed Web of Science ®Google Scholar
• Smith-Elkes S, Weinstein MP. Blood cultures. Infect Dis Clin North Am 1993; 7: 221–234
   PubMed Web of Science ®Google Scholar
• Li J, Plorde JJ, Carlson LG. Effects of volume and periodicity on blood cultures. J Clin Microbiol 1994; 32: 2829–2831
   PubMed Web of Science ®Google Scholar
• Pfaller MA, Sibley TK, Westfall LJ, Hoppe-Bauer JE, Keating MA, Murray PR. Clinical laboratory comparison of a slide blood culture system with a conventional broth system. J Clin Microbiol 1982; 16: 525–530
   PubMed Web of Science ®Google Scholar
• Weinstein MP, Reller LB, Mirett S, Wang W-LL, Alcid DV. Controlled evaluation of Trypticase soy broth in agar slide and conventional blood culture systems. J Clin Microbiol 1985; 21: 626–629
   PubMed Web of Science ®Google Scholar
• Hansen SL, Hetmanski J, Stwart BJ. Resinsprocess methods for improved isolation of organisms from blood and other body fluids. Am J Med 1983; 75: 31–36
   PubMed Web of Science ®Google Scholar
• Wright AJ, Thompson RL, McLimans CA, Wilson WR, Washington JA, II. The antimicrobial removal device: a microbiological and clinical evaluation. Am J Clin Pathol 1982; 78: 173–177
   PubMed Web of Science ®Google Scholar
• Wilson W, Weinstein M, Mirrett S, Reimer LG, Reller LB. Controlled comparison of The Bact/Alert and BACTEC 660/730 nonradiometric blood culture systems. J Clin Microbiol 1992; 30: 323–329
   PubMed Web of Science ®Google Scholar
• Krisher KK, Whyburn DR, Koepnick FE. Comparison of the BacT/Alert pediatric blood culture system, Pedi-BacT, with conventional culture using the 20-milliliter Becton-Dickinson supplemented peptone broth tube. J Clin Microbiol 1993; 31: 793–797
   PubMed Web of Science ®Google Scholar
• Nolte FS, Williams JM, Jerris RC, Morello JA, Leitch CD, Matushek S, Schwabe LD, Dorigan F, Kocka FE. Multicenter clinical evaluation of a continuous monitoring blood culture system using fluorescent-sensor technology (BACTEC 9240). J Clin Microbiol 1993; 31: 552–557
   PubMed Web of Science ®Google Scholar
• Zwadyk P, Pierson CL, Young C. Comparison of Difco ESP and Organon Teknika BacT/Alert continuous-monitoring blood culture systems. J Clin Microbiol 1994; 32: 1273–1279
   PubMed Web of Science ®Google Scholar
• Kern W, Kirchner S, Vanek E. Resin versus standard blood culture media used with the new BACTEC automated infrared system: an evaluation in febrile granulocytopenic patients. W Int J Med Microbiol 1990; 273: 156–163
   Web of Science ®Google Scholar